A histo-clinical score to predict evolution to radioactive iodine-refractory of the follicular cell-derived thyroid carcinoma (PREDIRAIR): a single-centre, prospective, cohort study.

Mebarki L, Andre E, Subtil F, Bournaud C, Borson-Chazot F, Lifante JC, Abeillon J, Castellnou S, Descotes F, Raverot V, Bertholon-Gregoire M, Ilie MD, Decaussin-Petrucci M, Lasolle H

Open source

DOI
10.1016/j.eclinm.2026.103839
Published
2026 Apr
Container
EClinicalMedicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.eclinm.2026.103839,
  title = {A histo-clinical score to predict evolution to radioactive iodine-refractory of the follicular cell-derived thyroid carcinoma (PREDIRAIR): a single-centre, prospective, cohort study.},
  author = {Mebarki L and Andre E and Subtil F and Bournaud C and Borson-Chazot F and Lifante JC and Abeillon J and Castellnou S and Descotes F and Raverot V and Bertholon-Gregoire M and Ilie MD and Decaussin-Petrucci M and Lasolle H},
  year = {2026},
  journal = {EClinicalMedicine},
  doi = {10.1016/j.eclinm.2026.103839},
  url = {https://doi.org/10.1016/j.eclinm.2026.103839}
}

RIS

TY  - JOUR
TI  - A histo-clinical score to predict evolution to radioactive iodine-refractory of the follicular cell-derived thyroid carcinoma (PREDIRAIR): a single-centre, prospective, cohort study.
AU  - Mebarki L
AU  - Andre E
AU  - Subtil F
AU  - Bournaud C
AU  - Borson-Chazot F
AU  - Lifante JC
AU  - Abeillon J
AU  - Castellnou S
AU  - Descotes F
AU  - Raverot V
AU  - Bertholon-Gregoire M
AU  - Ilie MD
AU  - Decaussin-Petrucci M
AU  - Lasolle H
PY  - 2026
JO  - EClinicalMedicine
DO  - 10.1016/j.eclinm.2026.103839
UR  - https://doi.org/10.1016/j.eclinm.2026.103839
ER  - 

APA

L, M., E, A., F, S., C, B., F, B., JC, L., J, A., S, C., F, D., V, R., M, B., MD, I., M, D., & H, L. (2026). A histo-clinical score to predict evolution to radioactive iodine-refractory of the follicular cell-derived thyroid carcinoma (PREDIRAIR): a single-centre, prospective, cohort study.. EClinicalMedicine. https://doi.org/10.1016/j.eclinm.2026.103839

Source records